isoxazoles has been researched along with Degenerative Disc Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aikawa, Y; Ito, H; Kawaguchi, Y; Kimura, T; Makino, H; Motomura, H; Nogami, M; Sainoh, T; Seki, S; Shiozawa, S; Tsumaki, N; Watanabe, K; Yahara, Y; Yamazaki, M | 1 |
| Cun, YP; Huang, B; Li, CQ; Liu, LT; Pan, Y; Wang, H; Wang, J; Xiong, CJ; Zhou, Y | 1 |
2 other study(ies) available for isoxazoles and Degenerative Disc Disease
| Article | Year |
|---|---|
A selective inhibition of c-Fos/activator protein-1 as a potential therapeutic target for intervertebral disc degeneration and associated pain.
Topics: Animals; Benzophenones; Cells, Cultured; Disease Models, Animal; Gene Expression Regulation; Humans; Interleukin-1beta; Intervertebral Disc Degeneration; Isoxazoles; Mice, Inbred C57BL; Molecular Targeted Therapy; Nucleus Pulposus; Pain; Proto-Oncogene Proteins c-fos; Rats, Sprague-Dawley; Transcription Factor AP-1 | 2017 |
Macrophage migration inhibitory factor inhibits the migration of cartilage end plate-derived stem cells by reacting with CD74.
Topics: Aged; Antigens, Differentiation, B-Lymphocyte; Cartilage; Cell Movement; Gene Knockdown Techniques; Histocompatibility Antigens Class II; Humans; Intervertebral Disc; Intervertebral Disc Degeneration; Isoxazoles; Macrophage Migration-Inhibitory Factors; Protein Binding; RNA, Small Interfering; Stem Cells; Tumor Necrosis Factor-alpha; Up-Regulation | 2012 |